AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
_02_05_2025_05_53_40_418159.jpg)
Clinigen Group Plc (LON:CLIN) is an international pharmaceutical and services company. The company runs with an objective to provide the proper medication to the right patient at the right time. They are catering the three areas of international medicine supply: unlicensed, licensed medicines and clinical trials. The company has international teams of more than 800 experts across 130 locations. The company has partnerships with more than 6000 pharmacists and 250 pharmaceutical companies.
CLIN â Financial highlights
On 25th February 2020, the company its interim results for the six months ended 31st December 2019.
The Adjusted Net Revenue increased to £224.6 million in six months ended 31st December 2019 as compared to the £181.1 million in six months ended 31st December 2018. The Adjusted Gross profit increased to £108.1 million in six months as compared to £80.0 million in six months ended 31st December 2018.
The EBITDA increased to £62.1 million in six months ended 31st December 2019 as compared to £43.7 million in six months ended 31st December 2018. The adjusted Earnings per share increased to 30.8 pence as compared to the 23.0 pence in six months ended 31st December 2018.
The Statutory Revenue increased to £243.7 million in six months ended 31st December 2019 as compared to the £208.9 million in six months ended 31st December 2018. The statutory gross profit increased to £108.1 million in six months ended 31st December 2019 as compared to the £80.0 million in the same period last year.
The interim dividend per share increased to 2.15 pence per share in six months ended 31st December 2019 as compared to the 1.95 pence per share in six months ended 31st December 2018. The Operating cash flow decreased to £10.1 million as compared to the £34.6 million in six months ended 31st December 2018.
The Net Debt increased to £322.3 million in six months ended 31st December 2019 as compared to the £192.4 million in six months ended 31st December 2018.
CLIN - Stock Price Performance
(Source: Thomson Reuters)Â
On 26th February 2020, at around 11:00 AM (GMT), by the time of writing this report, the stock of Clinigen Group Plc traded at a price of GBX 750.50 per share on the London Stock Exchange, an increase in the value of around 1.69 per cent or GBX 13.00 per share, as opposed to the closing price of the stock on the previous trading day, which has been reported to be at GBX 737.50 per share.
At the time of writing, the market capitalisation of Clinigen Group Plc was £979.76 million with regards to the current market price of the stock. The free float and outstanding shares of Clinigen Group Plc were reported at 127.23 million and 132.85 million, respectively.
The share price of Clinigen Group Plc recorded at GBX 1,069.0 as on 28th May 2019 was its 1-year peak price, whereas the share price recorded at GBX 733.0 as on 25th Feb 2020 was the 1-year low share price. The current share price was lower by 29.8 per cent from the 1-year high price, whereas the current share price was higher by 2.3 per cent from the 1-year low price.
The beta of the Clinigen Group Plc stock has been reported at a value of 1.0, representing the fact that the movement of the share price of the company is in-line with the movement in the comparative benchmark index.
dotDigital Group Plc
dotDigital Group plc (LON:DOTD) is a company empowering digital marketing professionals by providing them with omnichannel SaaS technology and email marketing. Its automated platform for marketing is used in 156 countries globally. The company was founded in the year 1999 as a web design organisation.
DOTD â Financial Highlights
On 25th February 2020, the company its interim results for the six months ended 31st December 2019.
The organic Revenue increased to £23.1 million as compared to the £20.1 million in six months ended 31st December 2018. The gross profit increased to £20.6 million as compared to the £17.8 million in six months ended 31st December 2018.
The operating profit from continuing operations increased to £6.6 million in six months ended 31st December 2019 as compared to the £4.7 million in six months ended 31st December 2018. The Profit before income tax from continuing operations increased to £6.5 million as compared to the £4.7 million in six months ended 31st December 2018.
The Profit for the period attributable to the owners of the Company increased to £5.5 million in six months ended 31st December 2019 as compared to the £4.3 million in six months ended 31st December 2018.
The basic earnings per share increased to 1.84 pence as compared to the 1.44 pence in the same period last year. The diluted earnings per share increased to 1.84 pence in six months ended 31st December 2019 as compared to the 1.42 pence in six months ended 31st December 2018.
DOTD - Stock Price Performance
(Source: Thomson Reuters)
On 26th February 2020, at around 11:33 AM (GMT), by the time of writing this report, the stock of dotDigital Group plc traded at a price of GBX 103.0 per share on the London Stock Exchange, a decrease in the value of around 1.90 per cent or GBX 2.00 per share, as opposed to the closing price of the stock on the previous trading day, which has been reported to be at GBX 105.00 per share.
At the time of writing, the market capitalisation of dotDigital Group plc was £312.78 million with regards to the current market price of the stock. The free float and outstanding shares of dotDigital Group plc were reported at 261.49 million and 297.89 million, respectively.
The share price of dotDigital Group plc recorded at GBX 116.0 as on 6th February 2020 was its 1-year peak price, whereas the share price recorded at GBX 83.87 as on 22nd November 2019 was the 1-year low share price. The current share price was lower by 11.2 per cent from the 1-year high price, whereas the current share price was higher by 22.8 per cent from the 1-year low price.
The beta of the dotDigital Group plc stock has been reported at a value of 1.1, representing the fact that the movement of the share price of the company has high volatility as compared with the movement in the comparative benchmark index.
Derwent London Plc
Derwent London Plc (LON:DLN) is a highly advanced office expert property investors of London, which was founded by Simon Silver & John Burns in the year 1984. The company has an employee base of over 100 people, and the share of the company is listed on London stock exchange under FTSE 250. The company is famous for its creative management approach to advancement and design-led philosophy.
DLN â Financial Highlights
On 25th Feb 2020, the company released its full-year results for the period ended 31st Dec 2019.
The gross property and other income of the company increased to £230.3 million in the year 2019 as compared to £228.0 million in the year 2018. The profit from operations increased to £315.8 million as compared to £242.2 million in the year 2018.
The profit before tax increased to £280.6 million in the year 2019 as compared to £221.6 million in the year 2018. The profit of the year increased to £278.1 million as compared to £218.9 million in the year 2018.
The basic earnings per share increased to 253.82 pence as compared to 199.33 pence in the year 2018. The diluted earnings per share increased to 253.11 pence in the year 2019 as compared to 198.9 pence in the year 2018.
DLN - Stock Price Performance
(Source: Thomson Reuters)
On 26th February 2020, at around 11:24 AM (GMT), by the time of writing this report, the stock of Derwent London Plc traded at a price of GBX 4,208.0 per share on the London Stock Exchange, a decrease in the value of around 1.27 per cent or GBX 54.0 per share, as opposed to the closing price of the stock on the previous trading day, which has been reported to be at GBX 4,262.0 per share.
At the time of writing, the market capitalisation of Derwent London Plc was £4.76 billion with regards to the current market price of the stock. The free float and outstanding shares of Derwent London Plc were reported at 97.14 million and 111.77 million, respectively.
The share price of Derwent London Plc recorded at GBX 4,362.0 as on 25th February 2020 was its 1-year peak price, whereas the share price recorded at GBX 2,858.0 as on 05th August 2019 was the 1-year low share price. The current share price was lower by 3.53 per cent from the 1-year high price, whereas the current share price was higher by 47.23 per cent from the 1-year low price.
The beta of the Derwent London Plc stock has been reported at a value of 0.50, representing the fact that the movement of the share price of the company has less volatility as compared with the movement in the comparative benchmark index.
